World of DTC Marketing

FEBRUARY 2, 2022

Biogen will partner with Roche on the development, and potential sale of a promising cancer drug the Swiss pharma is advancing for several types of lymphoma, announcing Tuesday it’s exercised an option to share rights to the treatment. Food and Drug Administration on Biogen Inc.’s

Food and Drug Administration 239

Food and Drug Administration Physicians Side effects Doctors 239

Pharma Leaders

MAY 18, 2023

The US Food and Drug Administration (FDA) has accepted Ardelyx’s resubmitted New Drug Application (NDA) for XPHOZAH (tenapanor) to control serum phosphate in adult patients with chronic kidney disease on dialysis who have had an insufficient response or intolerance to a phosphate binder therapy.

Food and Drug Administration 52

Food and Drug Administration FDA Side effects Prospecting 52

pharmaphorum

OCTOBER 13, 2022

From developing and financing the therapy in a timely manner to market access challenges due to the lack of maturity and extensive evidence, and explaining the complex science to physicians and patients, there are a variety of hurdles to overcome before bringing this type of technology to market.

Food and Drug Administration 52

Food and Drug Administration Side effects Patients FDA 52

Pharmaceutical Technology

MAY 5, 2023

The sale of an illegally imported supplement being marketed as a weight-gain enhancer has been associated with cases of dizziness, cognitive impairment, and sedation, according to the US Food and Drug Administration (FDA).

Food and Drug Administration 52

Food and Drug Administration FDA Side effects Food 52

Pharma Marketing Network

JUNE 11, 2020

With me, today is John Mack, the original creator of Pharma Marketing and also known as Pharma Guy from far and wide. And I was surprised to see a letter on the homepage that said, “Hey, Pharma folks, I’m retiring. And bring back some memories for folks of pharma guy and how he came to be. Thanks for coming John.

Media 52

Media Pharma Ethics Consulting 52

European Pharmaceutical Review

DECEMBER 27, 2023

Chimeric antigen receptor (CAR) T cells are the first example of a “living drug”. The CAR T cells need to persist in the blood to expand and elicit maximal effect, and there is a correlation between expansion and persistence and response.

Manufacturing 82

Manufacturing Food and Drug Administration Patients Pharma 82